BioSpace News Archive

Advanced Radiotherapy Market Techniques to Aid in Treatment of Different Types of Cancer

Surge in number of cancer patients, technological advancements, and rise in awareness regarding radiotherapy procedures and devices led to increased adoption of radiotherapy.

April 5, 2022
·
2 min read
Bearpac Medical Announces CE Mark Certification for the Passio™ Pump Drainage System

Bearpac Medical, LLC is pleased to announce that it has received CE Mark certification for use of the Passio Pump Drainage System with indications for the intermittent drainage of recurrent and symptomatic pleural effusions and malignant ascites.

April 5, 2022
·
1 min read
Lone Star Bio

CNS Pharmaceuticals Receives Approval from Competent Authority of Switzerland for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

CNS Pharmaceuticals, Inc. today announced it has received approval from Swissmedic, the Swiss Agency for Therapeutic Products, for the Company’s potentially pivotal study of Berubicin.

April 5, 2022
·
6 min read
Drug Development

CEFALY Publishes the First and Largest, Phase 3 Clinical Trial of 2-hour External Trigeminal Nerve Stimulation (e-TNS) for At-Home Acute Migraine Treatment

CEFALY Technology, today announced the results of a clinical study demonstrating that two-hour treatment with the e-TNS CEFALY device is a safe and effective, non-pharmaceutical alternative for the acute treatment of migraine attacks in the out-of-hospital setting.

April 5, 2022
·
4 min read
Deals

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

Valo Health, LLC (“Valo”), announced today the acquisition of TARA Biosystems, Inc. (“TARA”), a New York City-based cardiovascular disease biotechnology company, creating the first of its kind vertically integrated cardiovascular drug discovery and development platform.

April 5, 2022
·
3 min read
Genetown

Theseus Pharmaceuticals to Participate Virtually in Needham Healthcare Conference

Theseus Pharmaceuticals, Inc. announced that it will participate in the 21st Annual Needham Virtual Healthcare Conference, taking place April 11-14, 2022.

April 5, 2022
·
2 min read
Drug Development

Bond Biosciences Announces First Dosing of Sentinel Patients in a Phase Ia/b Clinical Trial for a Novel Therapy to Treat Patients with Hemochromatosis

Bond Biosciences Announces First Dosing of Sentinel Patients in a Phase Ia/b Clinical Trial for a Novel Therapy to Treat Patients with Hemochromatosis.

April 5, 2022
·
2 min read
Business

Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th

Aditxt Signs Revenue-Sharing Agreement with Cellvera for up to $30M, and Hosts a Live Business Update Webinar on April 14th.

April 5, 2022
·
9 min read
Business

Jaguar Health Announces Appointment of Pravin Chaturvedi, Ph.D., as Chief Scientific Officer

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Pravin Chaturvedi, PhD, a pharmaceutical veteran and leading clinical development expert, has been appointed Chief Scientific Officer (CSO) and Chair of the Scientific Advisory Board (SAB) of Jaguar.

April 5, 2022
·
10 min read
Deals

Advanced Dermatology and Cosmetic Surgery Acquires Maragh Dermatology, Surgery and Vein Institute

Advanced Dermatology and Cosmetic Surgery announces Maragh Dermatology, Surgery and Vein Institute, has joined its brand family of over 150 offices nationwide.

April 5, 2022
·
4 min read